Sequent Scientific’s (SSL) 4QFY22 revenue at Rs3,837mn was broadly in line with our estimate. However, EBITDA and net profit declined by 8% QoQ and 48% QoQ, respectively.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.